Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Dr. David Kessler has been selected by President-elect Joe Biden to lead coronavirus vaccine efforts. (Photo: Brainstorm Health/Flickr/cc)

Dr. David Kessler, formerly head of the U.S. Food and Drug Administration, has been tapped by President-elect Joe Biden to head the government's coronavirus vaccine effort. (Photo: Brainstorm Health/Flickr/cc)

In Face of Trump Failures, Health Experts Welcome Biden's Choice to Take Over Covid-19 Vaccine Effort

"The nation and the world need someone of Dr. Kessler's caliber to deal with the remaining, colossal challenges with coronavirus vaccines," said Public Citizen president Robert Weissman. 

Brett Wilkins

Public health advocates on Friday applauded President-elect Joe Biden's selection of Dr. David Kessler—a pediatrician, attorney, author, hospital and academic administrator, and former commissioner of the U.S. Food and Drug Administration—to lead the government's effort to accelerate the development and deployment of coronavirus vaccines and treatments. 

"At FDA and elsewhere, David was known as the guy who got stuff done. I think when it comes to vaccines, we all want a person running it who can get stuff done."
—Dr. Ashish K. Jha
 Brown University School of Public Health  

The New York Times reports Kessler has been a key adviser to Biden on coronavirus policy and currently serves as co-chair of the transition team's Covid-19 task force. He will replace Dr. Moncef Slaoui, the former pharmaceutical industry executive who currently heads Operation Warp Speed, the Trump administration's vaccine program.

Slaoui, who submitted his resignation Tuesday at the request of the Biden team—which has reportedly dropped the Warp Speed moniker—will reportedly remain for a month as a consultant. 

"Dr. Kessler became a trusted adviser to the Biden campaign and to President-elect Biden at the beginning of the pandemic, and has probably briefed Biden 50 or 60 times since March," Anita Dunn, co-chair of the transition team, told the Times. "When staff gets asked, 'What do the doctors say?,' we know that David Kessler is one of the doctors that President-elect Biden expects us to have consulted."

Kessler is a close associate of Dr. Anthony Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases and point-man on the coronavirus pandemic. Kessler will work toward achieving Biden's objective of vaccinating 100 million people in the first 100 days of his presidency, part of an ambitious $400 billion plan to combat the pandemic. 

The appointment comes at a critical time, as U.S. coronavirus infections, hospitalizations, and deaths have all reached record levels in recent weeks, with nearly 23.4 million cases and more than 390,000 deaths—roughly the population of Cleveland—reported by Johns Hopkins University's Coronavirus Resource Center on January 15.

Leaders and advocates in the field of public health welcomed the news of Kessler's selection. 

"The nation and the world need someone of Dr. Kessler's caliber to deal with the remaining, colossal challenges with coronavirus vaccines: to ensure expedited deployment in the U.S., and to massively increase production to enable rapid vaccination in developing countries," said Robert Weissman, president of Public Citizen, the consumer advocacy group founded by Ralph Nader in 1971.

"It is crucial that Operation Warp Speed leverage its investments, relationships, and authority to develop U.S. governmental manufacturing capacity and to facilitate sharing of vaccine technology and know-how with all qualified manufacturers around the world," added Weissman. "The alternative is far too horrible to tolerate."

Kessler led the FDA for over six years during the George H.W. Bush and Bill Clinton administrations, helping to speed the development and approval of AIDS drugs during the second decade of the global HIV epidemic. 

At the FDA, Kessler successfully took on Big Tobacco, proving with federal investigator Jack Mitchell and others that tobacco companies knew for half a century that their products were highly addictive. Their work led to the landmark $206 billion Master Settlement and passage of the Family Smoking Prevention and Tobacco Control Act. He also oversaw the FDA-directed moratorium on silicone breast implants. 

Kessler has also served as dean of the Yale School of Medicine and dean and vice-chancellor of the University of California, San Francisco Medical School, which fired him in 2007 after he blew the whistle on financial irregularities. The school later apologized and Kessler rejoined its faculty. 

While studying for his medical degree at Harvard Medical School, Kessler also earned a juris doctorate at the University of Chicago Law School and later simultaneously taught at Columbia Law School and the Albert Einstein College of Medicine, both in New York City.  

In 2018, Kessler was named chairman of the board of the Center for Science in the Public Interest, a consumer advocacy organization focusing on "improving the food system to support healthy eating." He is the author of the 2009 New York Times bestseller The End of Overeating, among other books.  


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

$158,000 Cost for ALS Treatment Called 'A Poster Child' for Unjust Drug Pricing

"The price of the newly approved drug combination Relyvrio to treat ALS," said one critic, "is yet another clear and powerful example of unjustified high prices set by drug companies that ultimately exploit patients."

Jake Johnson ·


The Onion Files 'Masterfully Written' Amicus Brief in Support of Jailed Parodist

"As the globe's premier parodists, The Onion's writers also have a self-serving interest in preventing political authorities from imprisoning humorists."

Brett Wilkins ·


Jayapal Accuses Democratic Leaders of Botching Stock Trading Ban

"This should have been a no-brainer," said the Washington Democrat.

Julia Conley ·


Climate Coalition Pushes Social Media CEOs to End Planet-Killing Disinformation

"Platforms owe it to their users and the planet to stop amplifying the climate disinformation that undermines our ability to combat the climate crisis."

Jake Johnson ·


Supreme Court Poised to Shred What's Left of Voting Rights Act, Plaintiffs Warn

"If the court sides with Alabama," wrote a pair of plaintiffs in Merrill v. Milligan, "political opportunities for people of color will disappear."

Kenny Stancil ·

Common Dreams Logo